Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Binocular UDVA (logMAR)

From: Safety and effectiveness of the SUPRACOR presbyopic LASIK algorithm on hyperopic patients

Binocular UDVA Group A
Bilateral Supracor
Group B
Supracor + Standard LASIK
Group C
Supracor + Untreated
One way ANOVA (p value)
Pre OP 0.63 ± 0.18 (20/80) 0.43 ± 0.21 (20/50) 0.04 ± 0.06 (20/20) 0.00
1 Month 0.09 ± 0.10 (20/25) 0.03 ± 0.05 (20/20) 0.04 ± 0.05 (20/20) 0.12
3 Months 0.01 ± 0.00 (20/20) 0.03 ± 0.06 (20/20) 0.07 ± 0.06 (20/20) 0.15
6 Months 0.02 ± 0.05 (20/20) 0.00 ± 0.00 (20/20) 0.02 ± 0.05 (20/20) 0.36